Genomics and drug discovery

被引：6
|
作者：
Haseltine, WA [1 ]
机构：
[1] Human Genome Sci Inc, Rockville, MD 20850 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2001年 / 45卷 / 03期
关键词：
D O I：
10.1067/mjd.2001.117383
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Genomics, the systematic study of all the genes of an organism, offers a new and much-needed source of systematic productivity for the pharmaceutical industry The isolation of the majority of human genes in their most useful form is leading to the creation of new drugs based on human proteins, antibodies, peptides, and genes. Human Genome Sciences, Inc, was the first company to use the systematic, genomics approach to discovering drugs, and we have placed 4 of these in clinical trials. Two are described: repifermin (keratinocyte growth factor-2, KGF-2) for wound healing and treatment of mucositis caused by cancer therapy, and B lymphocyte stimulator (BLyS) for stimulation of the immune system. An anti-BLyS antibody drug is in advanced preclinical development for treatment of autoimmune diseases.
引用
收藏
页码：473 / 475
页数：3
相关论文
共 50 条
  • [41] Bacterial genomics - Potential for antimicrobial drug discovery
    Fritz, B
    Raczniak, GA
    BIODRUGS, 2002, 16 (05) : 331 - 337
  • [42] Structural genomics and drug discovery: all in the family
    Weigelt, Johan
    McBroom-Cerajewski, Linda D. B.
    Schapira, Matthieu
    Zhao, Yong
    Arrowmsmith, Cheryl H.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (01) : 32 - 39
  • [43] Key strategies in functional genomics for drug discovery
    Lawrence, RN
    DRUG DISCOVERY TODAY, 2000, 5 (12) : 536 - 538
  • [44] Functional genomics in virology and antiviral drug discovery
    DeFilippis, V
    Raggo, C
    Moses, A
    Früh, K
    TRENDS IN BIOTECHNOLOGY, 2003, 21 (10) : 452 - 457
  • [45] Antibacterial drug discovery - Then, now and the genomics future
    Monaghan, RL
    Barrett, JF
    BIOCHEMICAL PHARMACOLOGY, 2006, 71 (07) : 901 - 909
  • [46] Functional Genomics for Cancer Drug Target Discovery
    Haley, Benjamin
    Roudnicky, Filip
    CANCER CELL, 2020, 38 (01) : 31 - 43
  • [47] Functional genomics and cancer drug target discovery
    Moody, Susan E.
    Boehm, Jesse S.
    Barbie, David A.
    Hahn, William C.
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2010, 12 (03) : 284 - 293
  • [48] Drug discovery and development using chemical genomics
    Sehgal, A
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2002, 5 (04) : 526 - 531
  • [49] THE TUBERCULOSIS STRUCTURAL GENOMICS CONSORTIUM: A STRUCTURAL GENOMICS APPROACH TO DRUG DISCOVERY
    Musa, Tracey L.
    Ioerger, Thomas R.
    Sacchettini, James C.
    STRUCTURAL GENOMICS, PART C, 2009, 77 : 41 - 76
  • [50] Microbial genomics and drug discovery: Exploring innovative routes of drug discovery in the postgenomic era
    Dougherty, TJ
    Miller, PF
    IDRUGS, 2006, 9 (06) : 420 - 422
12345